Shalby

Shalby EBITDA per Employee

The EBITDA per Employee of Shalby (SHALBY.NS) as of Oct 25, 2026 is 274,275.58 INR. In the previous year, EBITDA per Employee was 495,168.04 INR — a change of -44.61% (lower).

EBITDA per Employee

274,275.58INR

YoY

-44.61%

Last updated:

EBITDA per Employee of Shalby is 2026 274,275.58 INR. EBITDA per Employee of Shalby was 2025 495,168.04 INR. It decreases by -44.61% lower compared to the previous year.

The Shalby EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2019
346,280.81 INR
Jan 1, 2020
373,995.52 INR
Jan 1, 2021
345,496.64 INR
Jan 1, 2022
462,882.75 INR
Jan 1, 2023
527,565.35 INR
Jan 1, 2024
1.03 M INR
Jan 1, 2025
495,168.04 INR
Jan 1, 2026
274,275.58 INR
The Shalby EBITDA per Employee history
YEAREBITDA per EmployeeYoY
274,275.58INR-44.61%
495,168.04INR-51.99%
1.03 MINR+95.48%
527,565.35INR+13.97%
462,882.75INR+33.98%
345,496.64INR-7.62%
373,995.52INR+8.00%
346,280.81INR+0.80%
343,525.02INR+25.53%
273,666.92INR+29.26%
211,713.97INR-18.17%
258,711.73INR+8.50%
238,442.87INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Shalby Stock analysis

What does Shalby do? Shalby Ltd operates hospitals and outpatient clinics in Ahmedabad, Gujarat, with 2,678 full-time employees. The company generates revenue through its Healthcare Services segment, which includes managing hospitals and medical diagnostic services, and its Manufacturing segment focused on producing implants. Key specialties driving demand include joint replacement surgery, critical care, spine surgery, neurology, cardiology, and organ transplants such as kidney and liver procedures. Patients seeking specialized treatments, including ortho-oncology, IVF, and bariatric surgery, form the primary customer base for its healthcare services. The firm's manufacturing division produces medical implants, serving hospitals and clinics under its own brand. Services like homecare, dental cosmetics, and ophthalmology cater to a diverse patient demographic. Revenue streams are derived from both direct patient care and the supply of implants to its own facilities, with no external brands or partnerships mentioned in the business description. Shalby Ltd's business model relies on integrated healthcare delivery across multiple specialties, combining hospital management, diagnostic services, and implant manufacturing. The company's focus on high-demand medical procedures ensures consistent patient flow, while its manufacturing segment supports internal operations without external sales. All services are provided within its owned facilities, emphasizing a vertically integrated approach to healthcare delivery. Shalby is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shalby stock

EBITDA per Employee of Shalby is 274,275.58 INR in 2026.

EBITDA per Employee of Shalby changed from 495,168.04 INR to 274,275.58 INR, representing a -44.61% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Shalby since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Shalby historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Shalby

All Key Metrics — Shalby